Researchers report a drug discovery strategy using tailor-made cyclic peptides to target β-arrestins, key regulators of ...
Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells have already transformed the treatment of blood cancers. Yet, despite their ...
In this piece, I highlight one particular talk that caught my interest — given by Elana Fertig, Dean E. Albert Reece Endowed ...
Cancer begins when mutations in specific genes override the body’s built-in controls on cell division, allowing rogue cells ...